Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - loperamide hydrochloride - oral capsule - 2mg

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

mcneil products ltd - loperamide hydrochloride; simeticone - oral tablet - 2mg ; 125mg

Malezija - engleski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

johnson & johnson sdn bhd - loperamide hydrochloride -

Malezija - engleski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

prime pharmaceutical sdn. bhd. - loperamide hydrochloride -

Kanada - engleski - Health Canada

mcneil consumer healthcare division of johnson & johnson inc - loperamide hydrochloride - tablet - 2mg - loperamide hydrochloride 2mg - antidiarrhea agents

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

mcneil consumer healthcare - loperamide hydrochloride (unii: 77ti35393c) (loperamide - unii:6x9oc3h4ii) - capsule - 2 mg - imodium® (loperamide hydrochloride) is indicated for the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease. imodium® is also indicated for reducing the volume of discharge from ileostomies. imodium is contraindicated in patients with a known hypersensitivity to loperamide hydrochloride or to any of the excipients. imodium is contraindicated in patients with abdominal pain in the absence of diarrhea. imodium is not recommended in infants below 24 months of age. imodium should not be used as the primary therapy: a specific clinical study designed to assess the abuse potential of loperamide at high doses resulted in a finding of extremely low abuse potential. studies in morphine-dependent monkeys demonstrated that loperamide hydrochloride at doses above those recommended for humans prevented signs of morphine withdrawal. however, in humans, the naloxone challenge pupil test, which when positive indicates opiate-like effects, performed

Irska - engleski - HPRA (Health Products Regulatory Authority)

johnson & johnson (ireland) limited - loperamide hydrochloride - orodispersible tablet - 2 milligram(s) - antipropulsives; loperamide

Irska - engleski - HPRA (Health Products Regulatory Authority)

johnson & johnson (ireland) limited - loperamide hydrochloride; simeticone - tablet - 2 mg/125 milligram(s) - antipropulsives; loperamide, combinations

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - loperamide hydrochloride - oral solution - 200microgram/1ml

Irska - engleski - HPRA (Health Products Regulatory Authority)

jntl consumer health i (ireland) limited - loperamide hydrochloride; simeticone - tablet - antipropulsives; loperamide, combinations